Four Projections for Value-Based Drug Pricing Landscape in 2030

Panel speakers at the Abarca Forward pharmacy conference discussed their outlooks for value-based drug pricing models by the end of the decade, coming up with four main predictions going .  The first prediction, from Lyfegen’s CEO Girisha Fernando, is that the healthcare industry will have largely adopted a value-based pricing approach to drug formularies.

According to Katie Adams, “When determining the prices for these formularies, Fernando recommended that health plans focus on two main questions: How do these drugs impact patients’ health outcomes? And how do these therapies reduce costs for health systems or allow them to create better, more holistic treatment plans for patients?.”

To read more, click here.

(Source: Med City News, February 17^th, 2023)